WOCKPHARMA.BOWOCKPHARMA.BOBSE
Loading
Year-over-year earnings per share growth rate
Percentile
P51
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -24.79% |
| Q3 2025 | 186.80% |
| Q2 2025 | -252.23% |
| Q1 2025 | -272.53% |
| Q4 2024 | 161.90% |
| Q3 2024 | -54.74% |
| Q2 2024 | 91.84% |
| Q1 2024 | -102.43% |
| Q4 2023 | -7.08% |
| Q3 2023 | 42.13% |
| Q2 2023 | 35.10% |
| Q1 2023 | -116.01% |
| Q4 2022 | 49.66% |
| Q3 2022 | -183.41% |
| Q2 2022 | 78.11% |
| Q1 2022 | -3375.41% |
| Q4 2021 | -120.13% |
| Q3 2021 | 363.48% |
| Q2 2021 | 86.24% |
| Q1 2021 | -705.80% |
| Q4 2020 | 331.25% |
| Q3 2020 | 101.57% |
| Q2 2020 | -386.60% |
| Q1 2020 | -580.46% |
| Q4 2019 | 111.73% |
| Q3 2019 | -82.76% |
| Q2 2019 | 58.99% |
| Q1 2019 | -54.21% |
| Q4 2018 | -211.65% |
| Q3 2018 | 73.56% |
| Q2 2018 | 44.24% |
| Q1 2018 | -278.59% |
| Q4 2017 | -1130.00% |
| Q3 2017 | 99.19% |
| Q2 2017 | -134.41% |
| Q1 2017 | -223.98% |
| Q4 2016 | -416.88% |
| Q3 2016 | 6.94% |
| Q2 2016 | 149.66% |
| Q1 2016 | -152.54% |